Key facts
- It has raised $1.4M; the latest was Early Stage VC ($1.4M) in Jan 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for MUXMA
- ·The full record, as it builds
Funding rounds
No funding rounds for MUXMA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MUXMA
Manufacturer of intelligent health-focused technology equipment intended for monitoring and management purposes. The company offers sensor-based data collection, personalized analytics, and adaptive feedback mechanisms, enabling healthcare providers and wellness organizations to improve efficiency in patient oversight, enhance preventive care strategies, support individualized treatment planning, and strengthen long-term health outcomes through continuous tracking, real-time insights, and structured decision support.
- Sector
- Healthcare
- HQ
- Qingdao, China
- Founded
- 2022
- Website
- muxma.cn/
- Ownership
- Privately Held (backing)
MUXMA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MUXMA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MUXMA in its N-PORT filings yet. We sweep new filings monthly.